• Home
  • Store
    • Total Access Subscriptions
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • Toolkit
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » Are We Missing a Potentially Reversible Contributor to Cognitive Impairment?
Research Update

Are We Missing a Potentially Reversible Contributor to Cognitive Impairment?

January 1, 2026
Susan L. Siegfreid, MD
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Susan L. Siegfreid, MD. Dr. Siegfreid has no financial relationships with companies related to this material. 

PDF

Getting your Trinity Audio player ready...

Original Study: Bajaj JS et al, JAMA Network Open, 2024;7(1):e2353965

Study Type: Retrospective cohort study

Distinguishing dementia from hepatic encephalopathy (HE) isn’t always straightforward, especially when cirrhosis hasn’t been diagnosed. This national VA study asked how often liver disease might be an unrecognized, and potentially reversible, contributor to cognitive decline in older veterans labeled with dementia.

Researchers analyzed records from 177,422 veterans with a dementia diagnosis but no prior cirrhosis diagnosis. Using the Fibrosis-4 (FIB-4) index (age, aspartate/alanine aminotransferase, and platelet count), they looked for signs of advanced liver disease. About 10% had FIB-4 scores over 2.67 (suggesting advanced fibrosis) and 5% had scores over 3.25 (suggesting cirrhosis). Among those in the latter group, more than 95% had imaging or lab evidence consistent with cirrhosis. High FIB-4 scores were more common in non-White, Hispanic, urban-dwelling veterans and in those with alcohol use disorder, hepatitis B or C, or chronic kidney disease. 

The study did not report how many of these veterans actually had clinical HE, although prior literature shows that this condition occurs in at least 30%–40% of patients with cirrhosis (Vilstrup H et al, Hepatology 2014;60(2):715–735).

CARLAT TAKE
When evaluating cognitive decline, it’s worth remembering that not every “dementia” is neurodegenerative. This VA study found that a meaningful subset of older adults labeled with dementia had FIB-4 scores suggestive of advanced fibrosis (the stage just before cirrhosis) or cirrhosis, and many in the highest-risk group had corroborating lab or imaging findings. Advanced fibrosis or cirrhosis doesn’t necessarily mean a patient has HE, but HE is common in this stage of liver disease and can contribute to cognitive symptoms. Because HE can mimic dementia and is at least partly reversible, running a quick FIB-4 check can be worthwhile, especially in patients with alcohol use, viral hepatitis, or unexplained lab abnormalities. For a FIB-4 calculator, see: www.tinyurl.com/fdfe5nn. It’s a low-effort screen that might uncover a reversible cause of cognitive decline.

Hospital Psychiatry
KEYWORDS cirrhosis cognitive decline dementia hepatic encephalopathy liver disease
    Susan L. Siegfreid, MD

    Dose-Dependent Mortality Risk for Second-Generation Antipsychotics in Young Adults

    More from this author
    www.thecarlatreport.com
    Issue Date: January 1, 2026
    SUBSCRIBE NOW
    Table Of Contents
    Learning Objectives, Emerging Technologies in Hospital Psychiatry, CHPR, Jan/Feb/March 2026
    Transforming Psychiatric Documentation: The Rise of AI Scribes
    Beyond Meds: TMS in Acute Psychiatric Care
    AI-Assisted Therapy
    Telepsychiatry in Hospital Psychiatry: From Stopgap to Standard Care
    Are We Missing a Potentially Reversible Contributor to Cognitive Impairment?
    Ketamine Shows Only Modest Advantage Over Midazolam in Inpatient Depression Treatment
    From Acute to Maintenance: The Role of ECT in Long-Term Psychiatric Care
    CME Post-Test, Emerging Technologies in Hospital Psychiatry, CHPR, January/February/March 2026
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2716137939.jpg
      Child Psychiatry

      Living Without Illusions: Psychological Survival in a World of Persistent Hatred

      Today’s episode is one we’ve been sitting with for a long time. We’re talking about how to survive psychologically in a world where hatred is persistent, not abstract,...

      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2026 Carlat Publishing, LLC and Affiliates, All Rights Reserved.